Natus Medical files $112.162 million stock shelf

By Angela McDaniels

Seattle, April 24 - Natus Medical Inc. registered to sell up to $112.162 million of stock in an S-3 filing with the Securities and Exchange Commission.

Covered by the shelf are $100 million of common stock and 600,000 shares of common stock to be sold by selling stockholders at up to $20.27 each for a total of up to $12.162 million.

The company's stock (Nasdaq: BABY) closed at $19.42 on Monday.

Selling stockholders include D3 Family Fund LP, D3 Family Bulldog Fund LP, D3 Family Retirement Fund LP, D3 Children's Fund LP and D3 Offshore Fund LP, who together purchased 600,000 shares of common stock at $11.88 each for a total of $7.128 million in a private placement on Oct. 17, 2005.

Proceeds will be used for general corporate purposes including repayment of borrowings under the company's $10 million senior secured credit facility, which was used to fund the acquisition of Bio-logic Systems Corp. in January.

Natus Medical is based in San Carlos, Calif., and develops and markets products for the detection, treatment and tracking of common disorders in newborns and children.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.